Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health-care spending is on people with diabetes.
More Stories
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's...
Family offices are the most bullish they’ve been in years, survey says
Nearly half of family offices are expecting double-digit returns this year, according to Citi Private Bank's 2024 Global Family Office...
Ethereum Foundation sells 300 ETH as price hits $2.5k
The Ethereum Foundation has sold a total of 950 ETH worth over $2.2 million in the past three weeks. On...
The Biggest Concern After Fed Rate Cuts Is Not What You Think
At long last, after four years, the Federal Reserve has finally cut the Fed Funds rate by 50 basis points,...
Panthers-Raiders game marks a first for the NFL with two women presidents at the helm
Carolina Panthers President Kristi Coleman and Las Vegas Raiders President Sandra Douglass Morgan are the only two female presidents out...
American Airlines in talks to pick Citigroup over rival bank Barclays for crucial credit card deal, sources say
American has been working with banks and card networks on a new deal with the aim of consolidating its business...